Business Context and Reporting Period
Company: Wave Life Sciences Ltd.
Filing Type: Form 8-K (Current Report)
Date of Report: September 26, 2016
Event: Entry into a Material Definitive Agreement (Lease Agreement).
Key Financial Metrics
This filing reports on a specific contractual agreement rather than periodic financial performance. Consequently, revenue, profit, cash flow, margins, and debt levels are not disclosed in this document.
- Initial Lease Commitment: Approximately $2.8 million per year in average base rent for the initial term.
- Expansion Option Cost: Approximately $1.8 million per year in additional average base rent if exercised.
- Security Deposit: Approximately $2.6 million letter of credit required.
- Lease Term: 10 years and 9 months from the commencement date.
Material Changes
The Company entered into a new Lease Agreement with King 115 Hartwell LLC for a new Manufacturing Facility located at 115 Hartwell Avenue, Lexington, Massachusetts. This facility is intended to supplement the Company's existing U.S. headquarters in Cambridge, Massachusetts, to support GMP manufacturing activities and provide additional laboratory and office space.
Outlook and Management Commentary
- Occupancy Timeline: The Company expects to commence occupancy of the Manufacturing Facility by the end of the first quarter of 2017, with an anticipated commencement date of March 21, 2017.
- Expansion Rights: The Company has an option to expand the leased space by approximately 33,650 square feet (the remainder of the building) if exercised on or before December 31, 2016.
- Renewal Options: The lease includes options to renew for two successive terms of five years each.
- Additional Costs: The Company is responsible for a proportionate share of applicable taxes, operating expenses, and utilities in addition to base rent.
Investor Verification Checklist
- Verify the impact of the $2.6 million letter of credit requirement on the Company's current liquidity and cash reserves.
- Confirm the Company's ability to fund the build-out costs for the new Manufacturing Facility prior to the Q1 2017 occupancy date.
- Assess whether the Company intends to exercise the expansion option by the December 31, 2016 deadline.
- Review the full text of the Lease Agreement (Exhibit 10.1) for specific termination rights and default provisions.